NVO
Novo Nordisk A/SStock · Health CareMSCI EAFE 0.6% · MSCI World 0.2% · MSCI ACWI 0.1% · US Stock Market 0.0000%$43.24+0.12%
as of market close, Sep 18, 2026
☀ Pre $41.43 -4.19%
Novo Nordisk A/S returns by year
Through September 18, 2026
Novo Nordisk A/S returns by year (1982–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $50.88 | $43.24 | +4.2% | -10.8% | |
| 2025 | $86.02 | $50.88 | +1.6% | -39.2% | |
| 2024 | $103.45 | $86.02 | +0.9% | -15.9% | |
| 2023 | $67.67 | $103.45 | +1.6% | +54.5% | |
| 2022 | $56 | $67.67 | +1.8% | +22.6% | |
| 2021 | $34.93 | $56 | +3.1% | +63.4% | |
| 2020 | $28.94 | $34.93 | +2.6% | +23.3% | |
| 2019 | $23.04 | $28.94 | +3.0% | +28.7% | |
| 2018 | $26.84 | $23.04 | +2.3% | -11.9% | |
| 2017 | $17.93 | $26.84 | +3.3% | +52.9% | |
| 2016 | $29.04 | $17.93 | +1.2% | -37.0% | |
| 2015 | $21.16 | $29.04 | +1.5% | +38.7% | |
| 2014 | $18.48 | $21.16 | +1.6% | +16.1% | |
| 2013 | $16.32 | $18.48 | +1.6% | +14.8% | |
| 2012 | $11.53 | $16.32 | +1.8% | +43.4% | |
| 2011 | $11.26 | $11.53 | +1.1% | +3.5% | |
| 2010 | $6.39 | $11.26 | +2.2% | +78.5% | |
| 2009 | $5.14 | $6.39 | +2.1% | +26.3% | |
| 2008 | $6.49 | $5.14 | +0.8% | -20.0% | |
| 2007 | $4.18 | $6.49 | +1.7% | +56.8% | |
| 2006 | $2.81 | $4.18 | +1.7% | +50.3% | |
| 2005 | $2.71 | $2.81 | +1.1% | +4.9% | |
| 2004 | $2.05 | $2.71 | +1.5% | +34.0% | |
| 2003 | $1.45 | $2.05 | +1.6% | +43.3% | |
| 2002 | $2.01 | $1.45 | +0.5% | -27.4% | |
| 2001 | $1.77 | $2.01 | +0.7% | +13.9% | |
| 2000 | $1.29 | $1.77 | +0.9% | +37.8% | |
| 1999 | $1.33 | $1.29 | +0.8% | -2.0% | |
| 1998 | $1.44 | $1.33 | +0.4% | -7.4% | |
| 1997 | $0.94 | $1.44 | +0.7% | +55.0% | |
| 1996 | $0.69 | $0.94 | +0.8% | +37.3% | |
| 1995 | $0.48 | $0.69 | +0.0% | +44.2% | |
| 1994 | $0.5 | $0.48 | +0.0% | -4.0% | |
| 1993 | $0.44 | $0.5 | +0.0% | +11.5% | |
| 1992 | $0.45 | $0.44 | +0.0% | -0.8% | |
| 1991 | $0.31 | $0.45 | +0.0% | +43.5% | |
| 1990 | $0.25 | $0.31 | +0.0% | +24.5% | |
| 1989 | $0.19 | $0.25 | +0.0% | +29.3% | |
| 1988 | $0.11 | $0.19 | +0.0% | +81.1% | |
| 1987 | $0.16 | $0.11 | +0.0% | -34.9% | |
| 1986 | $0.15 | $0.16 | +0.1% | +12.0% | |
| 1985 | $0.12 | $0.15 | +0.0% | +23.6% | |
| 1984 | $0.28 | $0.12 | +0.0% | -57.6% | |
| 1983 | $0.22 | $0.28 | +0.0% | +27.6% | |
| 1982 | $0.18 | $0.22 | +0.0% | +21.9% |
- Annualized
- +14.0%
- 1982–2026
- Average year
- +19.6%
- 44 full years
- Best year
- +81.1%
- 1988
- Worst year
- -57.6%
- 1984
- Positive years
- 32/44
- 73% up
Annualized (CAGR)
+14.0%
1982–2026
Average year
+19.6%
44 full years
Best year
+81.1%
1988
Worst year
-57.6%
1984
Positive years
32/44
73% up
Total return by period#
Annual
-50%0%50%
1982+22%'82
1983+28%
1984-58%
1985+24%
1986+12%'86
1987-35%
1988+81%
1989+29%
1990+24%'90
1991+43%
1992-0.84%
1993+12%
1994-4.0%'94
1995+44%
1996+37%
1997+55%
1998-7.4%'98
1999-2.0%
2000+38%
2001+14%
2002-27%'02
2003+43%
2004+34%
2005+4.9%
2006+50%'06
2007+57%
2008-20%
2009+26%
2010+79%'10
2011+3.5%
2012+43%
2013+15%
2014+16%'14
2015+39%
2016-37%
2017+53%
2018-12%'18
2019+29%
2020+23%
2021+63%
2022+23%'22
2023+54%
2024-16%
2025-39%
2026-11%'26
Methodology#
Returns are total returns (dividends reinvested), computed from NVO's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Novo Nordisk A/S's average annual return?
- Since 1982, Novo Nordisk A/S (NVO) has returned about 14.0% a year (the compound annual growth rate) and an average calendar-year return of 19.6%.
- What were Novo Nordisk A/S's best and worst years?
- Over 1982–2026, the best year was 1988 (+81.1%) and the worst was 1984 (-57.6%).
- How often is Novo Nordisk A/S up in a year?
- 32 of the 44 full years since 1982 were positive — about 73% of the time.
More on Novo Nordisk A/S
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100